NCT05691049 - Evaluation of Efficacy and Safety of HCC_45 for the Correction of Acne Scars of the Face | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 24, 2022

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions

Acne Scars - Mixed Atrophic and HypertrophicIce Pick ScarsRolling ScarsBoxcar Scars

Interventions

DEVICE

HCC_45

"Dosage form: HCC\_45 is a resorbable medical device 2 ml non-pyrogenic pre-filled syringe, containing 2 ml of hyaluronic acid for intradermal use.~The principal component of the medical device is Hyaluronic Acid of non-animal origin, produced by bacterial fermentation."

Trial Locations (1)

Unknown

DERMING S.r.l., Clinical Research and Bioengineering Institute, Milan